- •Preface
- •List of contributers
- •History, epidemiology, prevention and education
- •A history of burn care
- •“Black sheep in surgical wards”
- •Toxaemia, plasmarrhea, or infection?
- •The Guinea Pig Club
- •Burns and sulfa drugs at Pearl Harbor
- •Burn center concept
- •Shock and resuscitation
- •Wound care and infection
- •Burn surgery
- •Inhalation injury and pulmonary care
- •Nutrition and the “Universal Trauma Model”
- •Rehabilitation
- •Conclusions
- •References
- •Epidemiology and prevention of burns throughout the world
- •Introduction
- •Epidemiology
- •The inequitable distribution of burns
- •Cost by age
- •Cost by mechanism
- •Limitations of data
- •Risk factors
- •Socioeconomic factors
- •Race and ethnicity
- •Age-related factors: children
- •Age-related factors: the elderly
- •Regional factors
- •Gender-related factors
- •Intent
- •Comorbidity
- •Agents
- •Non-electric domestic appliances
- •War, mass casualties, and terrorism
- •Interventions
- •Smoke detectors
- •Residential sprinklers
- •Hot water temperature regulation
- •Lamps and stoves
- •Fireworks legislation
- •Fire-safe cigarettes
- •Children’s sleepwear
- •Acid assaults
- •Burn care systems
- •Role of the World Health Organization
- •Conclusions and recommendations
- •Surveillance
- •Smoke alarms
- •Gender inequality
- •Community surveys
- •Acknowledgements
- •References
- •Prevention of burn injuries
- •Introduction
- •Burns prevalence and relevance
- •Burn injury risk factors
- •WHERE?
- •Burn prevention types
- •Burn prevention: The basics to design a plan
- •Flame burns
- •Prevention of scald burns
- •Conclusions
- •References
- •Burns associated with wars and disasters
- •Introduction
- •Wartime burns
- •Epidemiology of burns sustained during combat operations
- •Fluid resuscitation and initial burn care in theater
- •Evacuation of thermally-injured combat casualties
- •Care of host-nation burn patients
- •Disaster-related burns
- •Epidemiology
- •Treatment of disaster-related burns
- •The American Burn Association (ABA) disaster management plan
- •Summary
- •References
- •Education in burns
- •Introduction
- •Surgical education
- •Background
- •Simulation
- •Education in the internet era
- •Rotations as courses
- •Mentorship
- •Peer mentorship
- •Hierarchical mentorship
- •What is a mentor
- •Implementation
- •Interprofessional education
- •What is interprofessional education
- •Approaches to interprofessional education
- •References
- •European practice guidelines for burn care: Minimum level of burn care provision in Europe
- •Foreword
- •Background
- •Introduction
- •Burn injury and burn care in general
- •Conclusion
- •References
- •Pre-hospital and initial management of burns
- •Introduction
- •Modern care
- •Early management
- •At the accident
- •At a local hospital – stabilization prior to transport to the Burn Center
- •Transportation
- •References
- •Medical documentation of burn injuries
- •Introduction
- •Medical documentation of burn injuries
- •Contents of an up-to-date burns registry
- •Shortcomings in existing documentation systems designs
- •Burn depth
- •Burn depth as a dynamic process
- •Non-clinical methods to classify burn depth
- •Burn extent
- •Basic principles of determining the burn extent
- •Methods to determine burn extent
- •Computer aided three-dimensional documentation systems
- •Methods used by BurnCase 3D
- •Creating a comparable international database
- •Results
- •Conclusion
- •Financing and accomplishment
- •References
- •Pathophysiology of burn injury
- •Introduction
- •Local changes
- •Burn depth
- •Burn size
- •Systemic changes
- •Hypovolemia and rapid edema formation
- •Altered cellular membranes and cellular edema
- •Mediators of burn injury
- •Hemodynamic consequences of acute burns
- •Hypermetabolic response to burn injury
- •Glucose metabolism
- •Myocardial dysfunction
- •Effects on the renal system
- •Effects on the gastrointestinal system
- •Effects on the immune system
- •Summary and conclusion
- •References
- •Anesthesia for patients with acute burn injuries
- •Introduction
- •Preoperative evaluation
- •Monitors
- •Pharmacology
- •Postoperative care
- •References
- •Diagnosis and management of inhalation injury
- •Introduction
- •Effects of inhaled gases
- •Carbon monoxide
- •Cyanide toxicity
- •Upper airway injury
- •Lower airway injury
- •Diagnosis
- •Resuscitation after inhalation injury
- •Other treatment issues
- •Prognosis
- •Conclusions
- •References
- •Respiratory management
- •Airway management
- •(a) Endotracheal intubation
- •(b) Elective tracheostomy
- •Chest escharotomy
- •Conventional mechanical ventilation
- •Introduction
- •Pathophysiological principles
- •Low tidal volume and limited plateau pressure approaches
- •Permissive hypercapnia
- •The open-lung approach
- •PEEP
- •Lung recruitment maneuvers
- •Unconventional mechanical ventilation strategies
- •High-frequency percussive ventilation (HFPV)
- •High-frequency oscillatory ventilation
- •Airway pressure release ventilation (APRV)
- •Ventilator associated pneumonia (VAP)
- •(a) Prevention
- •(b) Treatment
- •References
- •Organ responses and organ support
- •Introduction
- •Burn shock and resuscitation
- •Post-burn hypermetabolism
- •Individual organ systems
- •Central nervous system
- •Peripheral nervous system
- •Pulmonary
- •Cardiovascular
- •Renal
- •Gastrointestinal tract
- •Conclusion
- •References
- •Critical care of thermally injured patient
- •Introduction
- •Oxidative stress control strategies
- •Fluid and cardiovascular management beyond 24 hours
- •Other organ function/dysfunction and support
- •The nervous system
- •Respiratory system and inhalation injury
- •Renal failure and renal replacement therapy
- •Gastro-intestinal system
- •Glucose control
- •Endocrine changes
- •Stress response (Fig. 2)
- •Low T3 syndrome
- •Gonadal depression
- •Thermal regulation
- •Metabolic modulation
- •Propranolol
- •Oxandrolone
- •Recombinant human growth hormone
- •Insulin
- •Electrolyte disorders
- •Sodium
- •Chloride
- •Calcium, phosphate and magnesium
- •Calcium
- •Bone demineralization and osteoporosis
- •Micronutrients and antioxidants
- •Thrombosis prophylaxis
- •Conclusion
- •References
- •Treatment of infection in burns
- •Introduction
- •Clinical management strategies
- •Pathophysiology of the burn wound
- •Burn wound infection
- •Cellulitis
- •Impetigo
- •Catheter related infections
- •Urinary tract infection
- •Tracheobronchitis
- •Pneumonia
- •Sepsis in the burn patient
- •The microbiology of burn wound infection
- •Sources of organisms
- •Gram-positive organisms
- •Gram-negative organisms
- •Infection control
- •Pharmacological considerations in the treatment of burn infections
- •Topical antimicrobial treatment
- •Systemic antimicrobial treatment (Table 3)
- •Gram-positive bacterial infections
- •Enterococcal bacterial infections
- •Gram-negative bacterial infections
- •Treatment of yeast and fungal infections
- •The Polyenes (Amphotericin B)
- •Azole antifungals
- •Echinocandin antifungals
- •Nucleoside analog antifungal (Flucytosine)
- •Conclusion
- •References
- •Acute treatment of severely burned pediatric patients
- •Introduction
- •Initial management of the burned child
- •Fluid resuscitation
- •Sepsis
- •Inhalation injury
- •Burn wound excision
- •Burn wound coverage
- •Metabolic response and nutritional support
- •Modulation of the hormonal and endocrine response
- •Recombinant human growth hormone
- •Insulin-like growth factor
- •Oxandrolone
- •Propranolol
- •Glucose control
- •Insulin
- •Metformin
- •Novel therapeutic options
- •Long-term responses
- •Conclusion
- •References
- •Adult burn management
- •Introduction
- •Epidemiology and aetiology
- •Pathophysiology
- •Assessment of the burn wound
- •Depth of burn
- •Size of the burn
- •Initial management of the burn wound
- •First aid
- •Burn blisters
- •Escharotomy
- •General care of the adult burn patient
- •Biological/Semi biological dressings
- •Topical antimicrobials
- •Biological dressings
- •Other dressings
- •Exposure
- •Deep partial thickness wound
- •Total wound excision
- •Serial wound excision and conservative management
- •Full thickness burns
- •Excision and autografting
- •Topical antimicrobials
- •Large full thickness burns
- •Serial excision
- •Mixed depth burn
- •Donor sites
- •Techniques of wound excision
- •Blood loss
- •Antibiotics
- •Anatomical considerations
- •Skin replacement
- •Autograft
- •Allograft
- •Other skin replacements
- •Cultured skin substitutes
- •Skin graft take
- •Rehabilitation and outcome
- •Future care
- •References
- •Burns in older adults
- •Introduction
- •Burn injury epidemiology
- •Pathophysiologic changes and implications for burn therapy
- •Aging
- •Comorbidities
- •Acute management challenges
- •Fluid resuscitation
- •Burn excision
- •Pain and sedation
- •End of life decisions
- •Summary of key points and recommendations
- •References
- •Acute management of facial burns
- •Introduction
- •Anatomy and pathophysiology
- •Management
- •General approach
- •Airway management
- •Facial burn wound management
- •Initial wound care
- •Topical agents
- •Biological dressings
- •Surgical burn wound excision of the face
- •Wound closure
- •Special areas and adjacent of the face
- •Eyelids
- •Nose and ears
- •Lips
- •Scalp
- •The neck
- •Catastrophic injury
- •Post healing rehabilitation and scar management
- •Outcome and reconstruction
- •Summary
- •References
- •Hand burns
- •Introduction
- •Initial evaluation and history
- •Initial wound management
- •Escharotomy and fasciotomy
- •Surgical management: Early excision and grafting
- •Skin substitutes
- •Amputation
- •Hand therapy
- •Secondary reconstruction
- •References
- •Treatment of burns – established and novel technology
- •Introduction
- •Partial thickness burns
- •Biological membranes – amnion and others
- •Xenograft
- •Full thickness burns
- •Dermal analogs
- •Keratinocyte coverage
- •Facial transplantation
- •Tissue engineering and stem cells
- •Gene therapy and growth factors
- •Conclusion
- •References
- •Wound healing
- •History of wound care
- •Types of wounds
- •Mechanisms of wound healing
- •Hemostasis
- •Proliferation
- •Epithelialization
- •Remodeling
- •Fetal wound healing
- •Stem cells
- •Abnormal wound healing
- •Impaired wound healing
- •Hypertrophic scars and keloids
- •Chronic non-healing wounds
- •Conclusions
- •References
- •Pain management after burn trauma
- •Introduction
- •Pathophysiology of pain after burn injuries
- •Nociceptive pain
- •Neuropathic pain
- •Sympathetically Maintained Pain (SMP)
- •Pain rating and documentation
- •Pain management and analgesics
- •Pharmacokinetics in severe burns
- •Form of administration [21]
- •Non-opioids (Table 1)
- •Paracetamol
- •Metamizole
- •Non-steroidal antirheumatics (NSAID)
- •Selective cyclooxygenasis-2-inhibitors
- •Opioids (Table 2)
- •Weak opioids
- •Strong opioids
- •Other analgesics
- •Ketamine (see also intensive care unit and analgosedation)
- •Anticonvulsants (Gabapentin and Pregabalin)
- •Antidepressants with analgesic effects
- •Regional anesthesia
- •Pain management without analgesics
- •Adequate communication
- •Psychological techniques [65]
- •Transcutaneous electrical nerve stimulation (TENS)
- •Particularities of burn pain
- •Wound pain
- •Breakthrough pain
- •Intervention-induced pain
- •Necrosectomy and skin grafting
- •Dressing change of large burn wounds and removal of clamps in skin grafts
- •Dressing change in smaller burn wounds, baths and physical therapy
- •Postoperative pain
- •Mental aspects
- •Intensive care unit
- •Opioid-induced hyperalgesia and opioid tolerance
- •Hypermetabolism
- •Psychic stress factors
- •Risk of infection
- •Monitoring [92]
- •Sedation monitoring
- •Analgesia monitoring (see Fig. 2)
- •Analgosedation (Table 3)
- •Sedation
- •Analgesia
- •References
- •Nutrition support for the burn patient
- •Background
- •Case presentation
- •Patient selection: Timing and route of nutritional support
- •Determining nutritional demands
- •What is an appropriate initial nutrition plan for this patient?
- •Formulations for nutritional support
- •Monitoring nutrition support
- •Optimal monitoring of nutritional status
- •Problems and complications of nutritional support
- •Conclusion
- •References
- •HBO and burns
- •Historical development
- •Contraindications for the use of HBO
- •Conclusion
- •References
- •Nursing management of the burn-injured person
- •Introduction
- •Incidence
- •Prevention
- •Pathophysiology
- •Severity factors
- •Local damage
- •Fluid and electrolyte shifts
- •Cardiovascular, gastrointestinal and renal system manifestations
- •Types of burn injuries
- •Thermal
- •Chemical
- •Electrical
- •Smoke and inhalation injury
- •Clinical manifestations
- •Subjective symptoms
- •Possible complications
- •Clinical management
- •Non-surgical care
- •Surgical care
- •Coordination of care: Burn nursing’s unique role
- •Nursing interventions: Emergent phase
- •Nursing interventions: Acute phase
- •Nursing interventions: Rehabilitative phase
- •Ongoing care
- •Infection prevention and control
- •Rehabilitation medicine
- •Nutrition
- •Pharmacology
- •Conclusion
- •References
- •Outpatient burn care
- •Introduction
- •Epidemiology
- •Accident causes
- •Care structures
- •Indications for inpatient treatment
- •Patient age
- •Total burned body surface area (TBSA)
- •Depth of the burn
- •Pre-existing conditions
- •Accompanying injuries
- •Special injuries
- •Treatment
- •Initial treatment
- •Pain therapy
- •Local treatment
- •Course of treatment
- •Complications
- •Infections
- •Follow-up care
- •References
- •Non-thermal burns
- •Electrical injury
- •Introduction
- •Pathophysiology
- •Initial assessment and acute care
- •Wound care
- •Diagnosis
- •Low voltage injuries
- •Lightning injuries
- •Complications
- •References
- •Symptoms, diagnosis and treatment of chemical burns
- •Chemical burns
- •Decontamination
- •Affection of different organ systems
- •Respiratory tract
- •Gastrointestinal tract
- •Hematological signs
- •Nephrologic symptoms
- •Skin
- •Nitric acid
- •Sulfuric acid
- •Caustic soda
- •Phenol
- •Summary
- •References
- •Necrotizing and exfoliative diseases of the skin
- •Introduction
- •Necrotizing diseases of the skin
- •Cellulitis
- •Staphylococcal scalded skin syndrome
- •Autoimmune blistering diseases
- •Epidermolysis bullosa acquisita
- •Necrotizing fasciitis
- •Purpura fulminans
- •Exfoliative diseases of the skin
- •Stevens-Johnson syndrome
- •Toxic epidermal necrolysis
- •Conclusion
- •References
- •Frostbite
- •Mechanism
- •Risk factors
- •Causes
- •Diagnosis
- •Treatment
- •Rewarming
- •Surgery
- •Sympathectomy
- •Vasodilators
- •Escharotomy and fasciotomy
- •Prognosis
- •Research
- •References
- •Subject index
A history of burn care
Conclusions
This review indicates that the advances in burn care achieved since WWII were not accidental, but depended on integrated laboratory and clinical research; generous national funding; centers of excellence focused on comprehensive burn care; highly skilled multidisciplinary clinical teams; and committed leadership. Reflecting on recent progress in the 1976 American Burn Association presidential address, Colonel Basil Pruitt noted the importance of a tight working relationship between clinicians and basic scientists, working together to solve problems of clinical significance [124]. This paradigm should be strengthened and expanded, since we have entered an era in which the number of large burns has declined nationwide [125]. As a result, we are challenged with the need for multicenter trials if we are to continue to make progress. Fortunately, the creation of the American Burn Association (ABA) Multicenter Trials Group, and federal funding of several proposals under ABA leadership, has created the framework and the opportunity for such collaboration. In a manner reminiscent of events in the UK and US during WWII, the recent conflicts in Iraq and Afghanistan [126] and the attacks of 11 September 2001 [127] have highlighted the importance of thermal injury as a national problem. As a result, the following multicenter trials are currently being initiated:
Outcomes after burn injury, using the National Burn Repository database
Transfusion triggers
Impact of occupational and physical therapy on outcomes
High-volume hemofiltration in burn patients with septic shock and renal failure
Rapid polymerase chain reaction (PCR) test for
Staphylococcus aureus infection
Community-based exercise
Enteral glutamine effect on infections
Inhalation injury scoring
The spirit of collaboration and inquiry embodied by these projects is the surest guarantee that they will bear fruit in the years to come.
References
[1]Pruitt BA, Goodwin CW, Mason AD Jr (2002) Epidemiological, demographic, and outcome characteristics of burn injury. In: Herndon DN (ed) Total burn care. W. B. Saunders, London, pp 16–30
[2]Wolf SE, Rose JK, Desai MH et al (1997) Mortality determinants in massive pediatric burns. An analysis of 103 children with > or = 80% TBSA burns ( > or = 70% full-thickness). Ann Surg 225(5): 554–565; discussion 565–569
[3]Artz CP (1970) Historical aspects of burn management. Surg Clin N A 50(6): 1193–1200
[4]Wallace AF (1987) Recent advances in the treatment of burns–1843–1858. Br J Plast Surg 40(2): 193–200
[5]Dunbar J (1934) Burn cases treated in Glasgow Royal Infirmary. Glasgow Medical Journal 122: 239–255
[6]Davidson EC (1925) Tannic acid in the treatment of burns. Surg Gynecol Obstet 41: 202–221
[7]Hupkens P, Boxma H, Dokter J (1995) Tannic acid as a topical agent in burns: historical considerations and implications for new developments. Burns 21(1): 57–61
[8]Underhill FP (1930) The significance of anhydremia in extensive superficial burns. JAMA 95: 852–857
[9]Blalock A (1931) Experimental shock. VII () The importance of the local loss of fluid in the production of the low blood pressure after burns. Arch Surg 22: 610–616
[10]Aldrich RH (1933) The role of infection in burns: the theory and treatment with special reference to gentian violet. N Engl J Med 208–309: 299
[11]Battle R (1978) Plastic surgery in the two world wars andintheyearsbetween.JRoySocMed 71(11): 844–848
[12]Mills SMH (2005) Burns down under: lessons lost, lessons learned. J Burn Care Rehab 26(1): 42–52
[13]Mayhew ER (2004) The Reconstruction of Warriors: Archibald McIndoe, the Royal Air Force and the Guinea Pig Club. Greenhill Books, London
[14]Jackson D (1978) Thirty years of burn treatment in Brit- ain–where now? Injury 10(1): 40–45
[15]Colebrook L (1936) Treatment of human puerperal infections, and of experimental infections in mice, with prontosil. Lancet i:1279–1286
[16]Lerner BH (1991) Scientific evidence versus therapeutic demand: the introduction of the sulfonamides revisited. Ann Intern Med 115(4): 315–320
[17]Clark AM, Gibson T, Colebrook L et al () Penicillin and propamide in burns: elimination of haemolytic streptococci and staphylococci. Lancet 1943: 605–609
[18]Colebrook L, Gibson T, Todd JP et al (1944) Studies of burns and scalds. (Reports of the burns unit, Royal Infirmary, Glasgow, 1942–43). Medical Research Council Special Report Series No. 249. London: His Majesty’s Stationery Office
[19]Lawrence JC (1995) Some aspects of burns and burns research at Birmingham Accident Hospital 1944–93: A.B. Wallace Memorial Lecture, 1994. Burns 21: 403–413
13
L. C. Cancio, S. E. Wolf
[20]Colebrook L (1945) A burns unit at the Birmingham Accident Hospital and Rehabilitation Centre. Nursing Times 6: 4–6
[21]Turk JL (1994) Leonard Colebrook: the chemotherapy and control of streptococcal infections. J Roy Soc Med 87(12): 727–728
[22]Lockwood JS (1946) War-time activities of the National Research Council and the Committee on Medical Research; with particular reference to team-work on studies of wounds and burns. Ann Surg 124: 314–327
[23]Stewart IP (1948) Organizing Scientific Research for War: The Administrative History of the Office of Scientific Research and Development. Little, Brown and Company, Boston
[24]Neushul P (1993) Science, government, and the mass production of penicillin. J Hist Med Allied Sci 48(4): 371–395
[25]Administrative History Section A, Bureau of Medicine and Surgery (1946) Pearl Harbor Navy Medical Activities (The United States Navy Medical Department at War, 1941–1945, vol. 1, parts 1–2. United States Naval Administrative History of World War II #68-A). Bureau of Medicine and Surgery, Washington, D. C.
[26]Lesch JE (2007) The First Miracle Drugs: How the Sulfa Drugs Transformed Medicine. Oxford University Press, Oxford
[27]Meleney FL (1943) The study of the prevention of infection in contaminated accidental wounds, compound fractures and burns. Ann Surg 118: 171–183
[28]Chain E, Florey HW, Gardner AD et al (1940) Penicillin as a chemotherapeutic agent. Lancet ii:226–228
[29]Ligon BL (2004) Penicillin: its discovery and early development. Semin Pediatr Infect Dis 15(1): 52–57
[30]Richards AN (1964) Production of penicillin in the United States (1941–46). Nature 4918: 441–445
[31]Cope O (1943) Forward. In: Aub JC, Beecher HK, Cannon B et al (eds) Management of the Cocoanut Grove Burns at the Massachusetts General Hospital. J .B. Lippincott Company, Philadelphia, pp 1–2
[32]National Research Council Division of Medical Sciences (1942). Treatment of burns. War Medicine 2: 334–339
[33]Cope O, Moore FD (1947) The redistribution of body water and the fluid therapy of the burned patient. Ann Surg 126: 1010–1045
[34]Harkins HN (1942) The treatment of burns in wartime. JAMA 119: 385–390
[35]Harkins HN (1942) The Treatment of Burns. Baillere, Tindall and Cox, London
[36]Whipple AO (1943) Basic principles in the treatment of thermal burns. Ann Surg: 187–191
[37]Saffle JR (1993) The 1942 fire at Boston’s Cocoanut Grove nightclub. Am J Surg 166(6): 581–591
[38]Follett GP (1943) The Boston fire: a challenge to our disaster service. Ann J Nurs 43: 4–8
[39]Faxson NW (1943) The problems of the hospital administration. In: Aub JC, Beecher HK, Cannon B et al (eds)
Management of the Cocoanut Grove Burns at the Massachusetts General Hospital. J.B. Lippincott Company, Philadelphia, pp 3–8
[40]Artz CP (1969) Burns in my lifetime. J Trauma 9(10): 827–833
[41]Pruitt BA Jr (1984) Forces and factors influencing trauma care: 1983 A.A.S.T. (American Association for the Surgery of Trauma) Presidential address. J Trauma 24(6): 463–470
[42]Heimbach DM (1988) American Burn Association 1988 presidential address “we can see so far because . . .”. J Burn Care Rehab 9(4): 340–346
[43]Pruitt BA Jr (1995) The integration of clinical care and laboratory research. A model for medical progress. Arch Surg 130(5): 461–471
[44]Pruitt BA Jr (2000) Centennial changes in surgical care and research. Ann Surg 232(3): 287–301
[45]Artz CP (1979) History of burns. In: Artz CP, Moncrief JA, Pruitt BA Jr (eds) Burns: A Team Approach Philadelphia: W.B. Saunders 1979. pp 3–16
[46]Dimick AR, Brigham PA, Sheehy EM (1993) The development of burn centers in North America. Journal of Burn Care & Rehabilitation 14(2 Pt 2): 284–299
[47]Cope O, Rhinelander FW (1943) The problem of burn shock complicated by pulmonary damage. In: Aub JC, Beecher HK, Cannon B et al (eds) Management of the Cocoanut Grove Burns at the Massachusetts General Hospital. J. B. Lippincott, Philadelphia, PA, pp 115–128
[48]Evans IE, Purnell OJ, Robinett PW et al (1952) Fluid and electrolyte requirements in severe burns. Ann Surg 135: 804–817
[49]Reiss E, Stirman JA, Artz CP et al (1953) Fluid and electrolyte balance in burns. JAMA 152: 1309–1313
[50]Baxter CR, Shires T (1968) Physiological response to crystalloid resuscitation of severe burns. Ann N Y Acad Sci 150(3): 874–894
[51]Pruitt BA Jr, Mason AD Jr, Moncrief JA (1971) Hemodynamic changes in the early postburn patient: the influence of fluid administration and of a vasodilator (hydralazine). J Trauma 11(1): 36–46
[52]Saffle JR (2007) The phenomenon of “fluid creep” in acute burn resuscitation. J Burn Care Res 28: 382–395
[53]Pruitt BA, Jr (2000) Protection from excessive resuscitation: “pushing the pendulum back”. J Trauma 49(3): 567–568
[54]Cope O (1943) The treatment of the surface burns. In: Aub JC, Beecher HK, Cannon B et al (eds) Management of the Cocoanut Grove Burns at the Massachusetts General Hospital. J.B. Lippincott Company, Philadelphia, pp 85–93
[55]Lyons C (1943) Problems of infection and chemotherapy. In: Aub JC, Beecher HK, Cannon B et al (eds) Management of the Cocoanut Grove Burns at the Massachusetts General Hospital. J. B. Lippincott Company, Philadelphia, pp 94–102
[56]Dalton ML (2003) Champ Lyons: an incomplete life. Ann Surg 237(5): 694–703
14
A history of burn care
[57]Lyons C (1943) Penicillin therapy of surgical infections in the U.S. Army: a report. JAMA 123: 1007–1018
[58]Liedberg NC, Reiss E, Artz CP (1954) Infection in burns. III. Septicemia, a common cause of death. Surg Gynecol Obstetr 99: 151–158
[59]Teplitz C, Davis D, Mason AD, Jr., Moncrief JA (1964) Pseudomonas burn wound sepsis. I () Pathogenesis of experimental pseudomonas burn wound sepsis. J Surg Res 4: 200–216
[60]Teplitz C, Davis D, Walker HL et al (1964) Pseudomonas burn wound sepsis: II Hematogenous infection at the junction of the burn wound and the unburned hypodermis. J Surg Res 4: 217–222
[61]Walker HL, Mason AD, Jr, Raulston GL (1964) Surface infection with Pseudomonas Aeruginosa. Ann Surg
160:297–305
[62]Pruitt BA, Jr., O’Neill JA, Jr, Moncrief JA, Lindberg RB (1968) Successful control of burn-wound sepsis. Jama 203(12): 1054–1056
[63]Jelenko Cd, Jelenko JM, Mendelson JA, Buxton RW (1966) The marfanil mystery. Surg Gynecol Obstetr 122(1): 121–127
[64]Mendelson JA, Lindsey D (1962) Sulfamylon (mafenide) and penicillin as expedient treatment of experimental massive open wounds with C () perfringens infection. J Trauma 2: 239–261
[65]Lindberg RB, Moncrief JA, Mason AD Jr (1968) Control of experimental and clinical burn wound sepsis by topical application of sulfamylon compounds. Ann N Y Acad Sci 150(3): 950–960
[66]Moyer CA, Brentano L, Gravens DL et al (1965) Treatment of large burns with 0.5% silver nitrate solution. Arch Surg 90: 812–867
[67]Fox CL Jr (1968) Silver sulfadiazine–a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg 96(2): 184–188
[68]Tredget EE, Shankowsky HA, Groeneveld A, Burrell R (1998) A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil 19(6): 531–537
[69]Cannon B (1943) Procedures in rehabilitation of the severely burned. In: Aub JC, Beecher HK, Cannon B et al (eds) Management of the Cocoanut Grove Burns at the Massachusetts General Hospital. J. B. Lippincott Company, Philadelphia, 1943, pp 103–110
[70]Artz CP, Soroff HS (1955) Modern concepts in the treatment of burns. JAMA 159: 411–417
[71]Dobbs ER (1999) Burn therapy of years ago. J Burn Care Rehabil 20(1 Pt 1): 62–66; discussion 61
[72]Jackson D (1954) A clinical study of the use of skin homografts for burns. Br J Plast Surg 7: 26–43
[73]Jackson D, Topley E, Cason JS, Lowbury EJL (1960) Primary excision and grafting of large burns. Ann Surg
152:167–189
[74]Janzekovic Z (2008) Once upon a time . . . how West discovered East. J Plast Reconstr Aesthet Surg 61: 240–244
[75]Janzekovic Z (1972) Early surgical treatment of the burned surface. Panminerva Medica 14(7–8): 228–232
[76]Tompkins RG, Burke JF, Schoenfeld DA et al (1986) Prompt eschar excision: a treatment system contributing to reduced burn mortality. A statistical evaluation of burn care at the Massachusetts General Hospital (1974–1984). Ann Surg 204(3): 272–281
[77]McManus WF, Mason AD Jr, Pruitt BA Jr (1989) Excision of the burn wound in patients with large burns. Arch Surg 124(6): 718–720
[78]Herndon DN, Parks DH (1986) Comparison of serial debridement and autografting and early massive excision with cadaver skin overlay in the treatment of large burns in children. J Trauma 26(2): 149–152
[79]Herndon DN, Barrow RE, Rutan RL et al (1989) A comparison of conservative versus early excision. Therapies in severely burned patients. Ann Surg 209(5): 547– 552; discussion 552–553
[80]Ong YS, Samuel M, Song C (2006) Meta-analysis of early excision of burns. Burns 32(2): 145–150
[81]Burke JF, Yannas IV, Quinby WC Jr et al (1981) Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 194(4): 413–428
[82]Gallico GG 3rd, O’Connor NE, Compton CC et al (1984) Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 311(7): 448–451
[83]Rue LW, III, Cioffi WG, McManus WF, Pruitt BA Jr (1993) Wound closure and outcome in extensively burned patients treated with cultured autologous keratinocytes. J Trauma 34(5): 662–667
[84]Barret JP, Wolf SE, Desai MH, Herndon DN (2000) Costefficacy of cultured epidermal autografts in massive pediatric burns. Ann Surg 231(6): 869–876
[85]Aub JC, Pittman H, Brues AM (1943) The pulmonary complications: a clinical description. In: Aub JC, Beecher HK, Cannon B et al (eds) Management of the Cocoanut Grove Burns at the Massachusetts General Hospital. J.B. Lippincott Company, Philadelphia, pp 34–40
[86]Morris MJ (2006) Acute respiratory distress syndrome in combat casualties: military medicine and advances in mechanical ventilation. Mil Med 171: 1039–1044
[87]Rosengart MR (2006) Critical care medicine: landmarks and legends. Surg Clin North Am 86: 1305–1321
[88]Shirani KZ, Pruitt BA Jr, Mason AD Jr (1987) The influence of inhalation injury and pneumonia on burn mortality. Ann Surg 205(1): 82–87
[89]Shimazu T, Yukioka T, Hubbard GB et al (1987) A doseresponsive model of smoke inhalation injury. Severityrelated alteration in cardiopulmonary function. Ann Surg 206(1): 89–98
[90]Herndon DN, Traber DL, Niehaus GD et al (1984) The pathophysiology of smoke inhalation injury in a sheep
15
L. C. Cancio, S. E. Wolf
model. Journal of Trauma-Injury Infection & Critical Care 24(12): 1044–1051
[91]Shimazu T, Yukioka T, Ikeuchi H et al (1996) Ventila- tion-perfusion alterations after smoke inhalation injury in an ovine model. J Appl Physiol 81(5): 2250–2259
[92]Traber DL, Hawkins HK, Enkhbaatar P et al (2007) The role of the bronchial circulation in the acute lung injury resulting from burn and smoke inhalation. Pulmonary Pharmacology & Therapeutics 20(2): 163–166
[93]Cioffi WG, Jr., Rue LW, 3d, Graves TA et al (1991) Prophylactic use of high-frequency percussive ventilation in patients with inhalation injury. Ann Surg 213(6): 575–582
[94]Enkhbaatar P, Herndon DN, Traber DL (2009) Use of nebulized heparin in the treatment of smoke inhalation injury. J Burn Care Res 30(1): 159–162
[95]Cuthbertson DP (1942) Post-shock metabolic response. Lancet i:433–437
[96]Cope O, Nardi GL, Quijano M et al (1953) Metabolic rate and thyroid function following acute thermal trauma in man. Ann Surg 137: 165–174
[97]Wilmore DW, Long JM, Mason AD Jr et al (1974) Catecholamines: mediator of the hypermetabolic response to thermal injury. Ann Surg 180(4): 653–669
[98]Wilmore DW, Curreri PW, Spitzer KW et al (1971) Supranormal dietary intake in thermally injured hypermetabolic patients. Surg Gynecol Obstetr 132(5): 881–886
[99]Curreri PW, Richmond D, Marvin J, Baxter CR (1974) Dietary requirements of patients with major burns. Journal of the American Dietetic Association 65(4): 415–417
[100]Wolf SE, Edelman LS, Kemalyan N et al (2006) Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized dou- ble-blind trial. J Burn Care Res 27(2): 131–139; discussion 140–141
[101]Herndon DN, Hart DW, Wolf SE et al (2001) Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 345(17): 1223–1229
[102]Sakurai Y, Aarsland A, Herndon DN et al (1995) Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg 222(3): 283–294; 294–297
[103]Cioffi WG, Gore DC, Rue LW 3rd et al (1994) Insulinlike growth factor-1 lowers protein oxidation in patients with thermal injury. Ann Surg 220(3): 310–319
[104]Spies M, Wolf SE, Barrow RE et al (2002) Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children. Crit Care Med 30(1): 83–88
[105]Wilmore DW, Moylan JA Jr, Bristow BF et al (1974) Anabolic effects of human growth hormone and high caloric feedings following thermal injury. Surg Gynecol Obstet 138(6): 875–884
[106]Hart DW, Wolf SE, Chinkes DL et al (2002) Beta-block- ade and growth hormone after burn. Ann Surg 236(4): 450–6; discussion 456–457
[107]Pereira C, Murphy K, Herndon D (2004) Outcome measures in burn care. Is mortality dead? Burns 30: 761–771
[108]Richard RL, Hedman TL, Quick CD et al (2008) A clarion to recommit and reaffirm burn rehabilitation. J Burn Care Res 29(3): 425–432
[109]Esselman PC, Thombs BD, Magyar-Russell G, Fauerbach JA (2006) Burn rehabilitation: state of the science. Am J Phys Med Rehabil 85(4): 383–413
[110]Watkins AL (1943) A note on physical therapy. In: Aub JC, Beecher HK, Cannon B et al (eds) Management of the Cocoanut Grove Burns at the Massachusetts General Hospital. J. B. Lippincott Company, Philadelphia, pp 111–114
[111]Moncrief JA (1958) Complications of burns. Ann Surg 147: 443–475
[112]Moncrief JA (1958) Third degree burns of the dorsum of the hand. Am J Surg 96: 535–544
[113]Willis B (1969) The use of orthoplast isoprene splints in the treatment of the acutely burned child: preliminary report. American Journal of Occupational Therapy 23(1): 57–61
[114]Larson DL, Abston S, Evans EB et al (1971) Techniques for decreasing scar formation and contractures in the burned patient. J Trauma 11(10): 807–823
[115]Schmitt MA, French L, Kalil ET (1991) How soon is safe? Ambulation of the patient with burns after low- er-extremity skin grafting. J Burn Care Rehabil 12(1): 33–37
[116]Burnsworth B, Krob MJ, Langer-Schnepp M (1992) Immediate ambulation of patients with lower-extremity grafts. Journal of Burn Care & Rehabilitation 13(1): 89–92
[117]Carrougher GJ, Hoffman HG, Nakamura D et al (2009) The effect of virtual reality on pain and range of motion in adults with burn injuries. J Burn Care Res 30(5): 785–791
[118]Yoder LH, Nayback AM, Gaylord K (2010) The evolution and utility of the burn specific health scale: a systematic review. Burns 36: 1143–1156
[119]Klein MB, Lezotte DL, Fauerbach JA et al (2007) The National Institute on Disability and Rehabilitation Research burn model system database: a tool for the multicenter study of the outcome of burn injury. J Burn Care Res 28(1): 84–96
[120]Esselman PC, Askay SW, Carrougher GJ et al (2007) Barriers to return to work after burn injuries. Archives of Physical Medicine & Rehabilitation 88(12 Suppl 2): 50–56
[121]Esselman PC, Ptacek JT, Kowalske K et al (2001) Community integration after burn injuries. J Burn Care Rehabil 22(3): 221–227
[122]Gaylord KM, Holcomb JB, Zolezzi ME (2009) A comparison of posttraumatic stress disorder between combat casualties and civilians treated at a military burn center. Journal of Trauma-Injury Infection & Critical Care 66(4 Suppl): 191–195
[123]Kwan P, Hori K, Ding J, Tredget EE (2009) Scar and contracture: biological principles. Hand Clinics 25(4): 511–528
16
A history of burn care
[124]Pruitt BA Jr (1977) Multidisciplinary care and research for burn injury: 1976 presidential address, American Burn Association meeting. J Trauma 17(4): 263–269
[125]Latenser BA, Miller SF, Bessey PQ et al (2007) National Burn Repository 2006: a ten-year review. J Burn Care Res 28(5): 635–658
[126]Kauvar DS, Cancio LC, Wolf SE et al (2006) Comparison of combat and non-combat burns from on-
going U. S. military operations. J Surg Res 132(2): 195–200
[127]Anonymous (2002) Rapid assessment of injuries among survivors of the terrorist attack on the World Trade Center–New York City, September 2001. MMWR
– Morbidity & Mortality Weekly Report 51(1):1–5
Correspondence: Dr. L. Cancio, USAISR, Ft. Sam Houston, TX 78234–6315, USA, E-mail: Lee.cancio@us.army.mil
17